Health Care & Life Sciences » Pharmaceuticals | DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own DAE HWA Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
153,206
0.84%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
66,591
0.37%
24,424
0.01%
04/30/2018
Vanguard Developed Markets Index Fund
66,304
0.36%
0
0%
07/31/2018
Government Pension Fund - Global (The)
65,222
0.36%
-60,618
0%
12/31/2017
DFA Emerging Markets Small Cap Series
58,936
0.32%
36,053
0.02%
01/31/2018
Vanguard FTSE All World (ex-US) Small Cap
26,317
0.14%
0
0.01%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
25,889
0.14%
0
0.01%
09/05/2018
Mirae Asset TIGER Health Care ETF
25,162
0.14%
6,027
0.48%
04/30/2018
Schwab International Small Cap Equity ETF
11,978
0.07%
0
0.02%
09/06/2018
Vanguard Pacific Stock Index Fund
10,363
0.06%
0
0%
07/31/2018

About DAE HWA Pharmaceutical Co.

View Profile
Address
495 Hanu-ro
Hoengseong-gun GA 25228
Korea, Republic Of
Employees -
Website http://www.dhpharm.co.kr
Updated 09/14/2018
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals Manufacturing and Distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials Manufacturing and Distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections.